# Karen Facey

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/karen-facey/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,233 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 26 |
| i10-index | 44 |
| Last Known Institution | Flint Institute Of Arts |
| OpenAlex ID | https://openalex.org/A5073230749 |
| ORCID iD | 0000-0001-6670-5271 |
| Works | 74 |

## Researcher papers

- [Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine](https://scholariq.org/papers/treatment-of-human-immunodeficiency-virus-infection-with-saquinavir-zidovudine/)
- [Patients' perspectives in health technology assessment: A route to robust evidence and fair deliberation](https://scholariq.org/papers/patients-perspectives-in-health-technology-assessment-a-route-to-robust-evidence/)
- [Rapid reviews versus full systematic reviews: An inventory of current methods and practice in health technology assessment](https://scholariq.org/papers/rapid-reviews-versus-full-systematic-reviews-an-inventory-of-current-methods-and/)
- [Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers](https://scholariq.org/papers/overview-of-the-clinical-effectiveness-of-positron-emission-tomography-imaging/)
- [RAPID VERSUS FULL SYSTEMATIC REVIEWS: VALIDITY IN CLINICAL PRACTICE?](https://scholariq.org/papers/rapid-versus-full-systematic-reviews-validity-in-clinical-practice/)
- [What principles should govern the use of managed entry agreements?](https://scholariq.org/papers/what-principles-should-govern-the-use-of-managed-entry-agreements/)
- [Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)](https://scholariq.org/papers/recommendations-from-the-european-working-group-for-value-assessment-and-funding/)
- [Patient Involvement in Health Technology Assessment](https://scholariq.org/papers/patient-involvement-in-health-technology-assessment/)
- [HTA programme response to the challenges of dealing with orphan medicinal products: Process evaluation in selected European countries](https://scholariq.org/papers/hta-programme-response-to-the-challenges-of-dealing-with-orphan-medicinal/)
- [Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders](https://scholariq.org/papers/real-world-evidence-to-support-payer-hta-decisions-about-highly-innovative/)
- [Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?](https://scholariq.org/papers/can-we-use-existing-guidance-to-support-the-development-of-robust-real-world/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Genomics and Rare Diseases](https://scholariq.org/topics/genomics-and-rare-diseases/)
- [Mental Health and Patient Involvement](https://scholariq.org/topics/mental-health-and-patient-involvement/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)

## Researcher university

- [Flint Institute Of Arts](https://scholariq.org/institutions/flint-institute-of-arts/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.